The Impact of Step Therapy on Individuals with Psoriatic Disease in the USA: Patient and Provider Perspectives
Abstract The management of psoriatic disease has been revolutionized by biologic medications in recent years. Despite their efficacy and safety, patients are often required by insurance plans in the USA or national formulary guidelines in other countries to try and fail other treatments first, which...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2025-05-01
|
| Series: | Dermatology and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s13555-025-01430-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849704131063709696 |
|---|---|
| author | Georgia Marquez-Grap Dayna L. Pham Andrea Leung Melissa C. Leeolou Allison Kranyak Wilson Liao |
| author_facet | Georgia Marquez-Grap Dayna L. Pham Andrea Leung Melissa C. Leeolou Allison Kranyak Wilson Liao |
| author_sort | Georgia Marquez-Grap |
| collection | DOAJ |
| description | Abstract The management of psoriatic disease has been revolutionized by biologic medications in recent years. Despite their efficacy and safety, patients are often required by insurance plans in the USA or national formulary guidelines in other countries to try and fail other treatments first, which is a strategy called step therapy. Originally designed to contain costs of specialty drugs, step therapy has a number of negative impacts on patients and providers, both personally and clinically. This article is coauthored by a patient with psoriasis and psoriatic arthritis who navigated step therapy. She describes her early experiences with psoriasis and achieving disease control with biologic medication, only to later be diagnosed with psoriatic arthritis and need to revise this treatment plan. She then explains how insurance denials and step therapy impact her life physically, emotionally, socially, and medically. This case is then discussed from the perspective of a dermatologist specializing in inflammatory skin disease. We highlight the psychosocial burden of psoriatic disease, as well as the burden of step therapy and its impacts on patients, providers, and the entire medical system. |
| format | Article |
| id | doaj-art-96acc8ee3eef4be88bac5e23f6a7b262 |
| institution | DOAJ |
| issn | 2193-8210 2190-9172 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Adis, Springer Healthcare |
| record_format | Article |
| series | Dermatology and Therapy |
| spelling | doaj-art-96acc8ee3eef4be88bac5e23f6a7b2622025-08-20T03:16:52ZengAdis, Springer HealthcareDermatology and Therapy2193-82102190-91722025-05-011571599160610.1007/s13555-025-01430-1The Impact of Step Therapy on Individuals with Psoriatic Disease in the USA: Patient and Provider PerspectivesGeorgia Marquez-Grap0Dayna L. Pham1Andrea Leung2Melissa C. Leeolou3Allison Kranyak4Wilson Liao5Department of Dermatology, University of California, San FranciscoPatient AuthorDepartment of Dermatology, University of California, San FranciscoDepartment of Dermatology, Stanford UniversityDepartment of Dermatology, University of California, San FranciscoDepartment of Dermatology, University of California, San FranciscoAbstract The management of psoriatic disease has been revolutionized by biologic medications in recent years. Despite their efficacy and safety, patients are often required by insurance plans in the USA or national formulary guidelines in other countries to try and fail other treatments first, which is a strategy called step therapy. Originally designed to contain costs of specialty drugs, step therapy has a number of negative impacts on patients and providers, both personally and clinically. This article is coauthored by a patient with psoriasis and psoriatic arthritis who navigated step therapy. She describes her early experiences with psoriasis and achieving disease control with biologic medication, only to later be diagnosed with psoriatic arthritis and need to revise this treatment plan. She then explains how insurance denials and step therapy impact her life physically, emotionally, socially, and medically. This case is then discussed from the perspective of a dermatologist specializing in inflammatory skin disease. We highlight the psychosocial burden of psoriatic disease, as well as the burden of step therapy and its impacts on patients, providers, and the entire medical system.https://doi.org/10.1007/s13555-025-01430-1BiologicsInsurancePrior authorizationPsoriasisPsoriatic arthritisStep therapy |
| spellingShingle | Georgia Marquez-Grap Dayna L. Pham Andrea Leung Melissa C. Leeolou Allison Kranyak Wilson Liao The Impact of Step Therapy on Individuals with Psoriatic Disease in the USA: Patient and Provider Perspectives Dermatology and Therapy Biologics Insurance Prior authorization Psoriasis Psoriatic arthritis Step therapy |
| title | The Impact of Step Therapy on Individuals with Psoriatic Disease in the USA: Patient and Provider Perspectives |
| title_full | The Impact of Step Therapy on Individuals with Psoriatic Disease in the USA: Patient and Provider Perspectives |
| title_fullStr | The Impact of Step Therapy on Individuals with Psoriatic Disease in the USA: Patient and Provider Perspectives |
| title_full_unstemmed | The Impact of Step Therapy on Individuals with Psoriatic Disease in the USA: Patient and Provider Perspectives |
| title_short | The Impact of Step Therapy on Individuals with Psoriatic Disease in the USA: Patient and Provider Perspectives |
| title_sort | impact of step therapy on individuals with psoriatic disease in the usa patient and provider perspectives |
| topic | Biologics Insurance Prior authorization Psoriasis Psoriatic arthritis Step therapy |
| url | https://doi.org/10.1007/s13555-025-01430-1 |
| work_keys_str_mv | AT georgiamarquezgrap theimpactofsteptherapyonindividualswithpsoriaticdiseaseintheusapatientandproviderperspectives AT daynalpham theimpactofsteptherapyonindividualswithpsoriaticdiseaseintheusapatientandproviderperspectives AT andrealeung theimpactofsteptherapyonindividualswithpsoriaticdiseaseintheusapatientandproviderperspectives AT melissacleeolou theimpactofsteptherapyonindividualswithpsoriaticdiseaseintheusapatientandproviderperspectives AT allisonkranyak theimpactofsteptherapyonindividualswithpsoriaticdiseaseintheusapatientandproviderperspectives AT wilsonliao theimpactofsteptherapyonindividualswithpsoriaticdiseaseintheusapatientandproviderperspectives AT georgiamarquezgrap impactofsteptherapyonindividualswithpsoriaticdiseaseintheusapatientandproviderperspectives AT daynalpham impactofsteptherapyonindividualswithpsoriaticdiseaseintheusapatientandproviderperspectives AT andrealeung impactofsteptherapyonindividualswithpsoriaticdiseaseintheusapatientandproviderperspectives AT melissacleeolou impactofsteptherapyonindividualswithpsoriaticdiseaseintheusapatientandproviderperspectives AT allisonkranyak impactofsteptherapyonindividualswithpsoriaticdiseaseintheusapatientandproviderperspectives AT wilsonliao impactofsteptherapyonindividualswithpsoriaticdiseaseintheusapatientandproviderperspectives |